Zika Ectodomain

Zika Ectodomain Recombinant
Cat. No.
BT10790
Source
Baculovirus Insect Cells.
Synonyms
Appearance
Sterile Filtered solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Recombinant Zika Ectodomain is a glycosylated protein, produced using baculovirus vectors in insect cells and its Mw is approximately 45kDa.
The Zika Ectodomain is a recombinant protein of the ectodomain of the envelope protein from the Suriname Zika virus strain.

Product Specs

Introduction
Zika virus (ZIKV) is a member of the Flaviviridae family and the Flavivirus genus. It is primarily transmitted through the bite of infected Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus, which are active during daylight hours. Zika virus shares a close relationship with other flaviviruses, including dengue, yellow fever, Japanese encephalitis, and West Nile viruses. Similar to these related viruses, Zika virus possesses an enveloped, icosahedral structure and contains a nonsegmented, single-stranded RNA genome of positive polarity. Zika fever, the illness caused by Zika virus infection, often presents with no or mild symptoms, resembling a mild case of dengue fever. Treatment typically involves rest and supportive care. Since February 2016, there has been growing concern regarding the potential link between Zika fever during pregnancy and congenital abnormalities in developing fetuses. Studies suggest that the virus can be transmitted from mother to child during pregnancy, potentially leading to adverse outcomes such as miscarriage or microcephaly, a condition characterized by abnormally small head size. However, it's important to note that the definitive causal relationship between Zika virus infection and microcephaly is still under investigation. Moreover, recent findings have established a connection between Zika virus infection and neurological complications in infected adults, including Guillain-Barré syndrome.
Description
Recombinant Zika Ectodomain, a glycosylated protein with an approximate molecular weight of 45 kDa, is produced through baculovirus expression in insect cells. This protein represents the ectodomain of the envelope protein derived from the Suriname Zika virus strain.
Physical Appearance
Sterile Filtered solution.
Formulation
The Zika Ectodomain is supplied in a solution containing 10mM Sodium phosphate (pH 7.2) and 150mM NaCl.
Stability
Zika Ectodomain should be stored at 4°C. Avoid freezing.
Purity
Purity is determined to be greater than 90.0% by SDS-PAGE analysis.
Source
Baculovirus Insect Cells.

Product Science Overview

Introduction to Zika Virus

The Zika virus (ZIKV) is an arthropod-borne virus belonging to the family Flaviviridae and the genus Flavivirus. It was first identified in a rhesus monkey in the Zika forest of Uganda in 1947 . ZIKV is classified into two primary lineages: African and Asian strains, which share over 95% amino acid identity . Unlike the closely related dengue virus (DENV), which has four different serotypes, ZIKV has a single serotype .

Zika Virus Envelope Protein

The envelope (E) protein of ZIKV plays a crucial role in the virus’s ability to infect host cells. It is responsible for virus attachment, entry, and fusion with the host cell membrane. The E protein is composed of three domains: DI, DII, and DIII. The ectodomain of the E protein, which includes these three domains, is a key target for vaccine development and diagnostic assays .

Recombinant Zika Ectodomain

Recombinant Zika ectodomain refers to the production of the ZIKV E protein ectodomain using recombinant DNA technology. This involves cloning the gene encoding the E protein into an expression vector, which is then introduced into a host cell system (such as E. coli, insect cells, or mammalian cells) to produce the protein. The recombinant protein can be purified and used for various applications, including vaccine development, diagnostic assays, and research studies .

Applications of Recombinant Zika Ectodomain
  1. Vaccine Development: The recombinant Zika ectodomain is used in the development of vaccines to elicit an immune response against ZIKV. For example, the Zika Virus Envelope Domain III (zEDIII) recombinant protein has been evaluated as a vaccine candidate. When delivered with a saponin-based nanoadjuvant, it enhances anti-Zika immune responses, including the production of neutralizing antibodies and splenocyte proliferation .

  2. Diagnostic Assays: Recombinant Zika ectodomain proteins are used in serological assays, such as ELISA, to detect antibodies against ZIKV in patient samples. These assays are essential for diagnosing Zika virus infections and monitoring immune responses in clinical trials .

  3. Research Studies: The recombinant Zika ectodomain is also used in research to study the structure and function of the E protein, as well as its interactions with host cell receptors and antibodies. This knowledge is crucial for understanding the mechanisms of ZIKV infection and developing effective therapeutics .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.